Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 452

1.

Radiation therapy with concomitant and adjuvant cisplatin and paclitaxel in high-risk cervical cancer: long-term follow-up.

Argenta PA, Ghebre R, Dusenbery KE, Chen MD, Judson PL, Downs LS Jr, Carson LF.

Eur J Gynaecol Oncol. 2006;27(3):231-5.

PMID:
16800247
2.

A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.

Martínez-Monge R, Gaztañaga M, Aramendía JM, Cambeiro M, Arbea L, Espinós J, Aristu JJ, Jurado M.

Int J Gynecol Cancer. 2010 Jan;20(1):133-40. doi: 10.1111/IGC.0b013e3181c057ff.

PMID:
20130514
3.

Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.

Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL.

Gynecol Oncol. 2005 Jan;96(1):168-72.

PMID:
15589596
4.

Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study.

Strauss HG, Kuhnt T, Laban C, Puschmann D, Pigorsch S, Dunst J, Koelbl H, Haensgen G.

Strahlenther Onkol. 2002 Jul;178(7):378-85.

PMID:
12163992
5.
6.

External beam radiotherapy and high-dose brachytherapy combined with cisplatin and paclitaxel in patients with advanced cervical carcinoma.

Petera J, Odrázka K, Frgala T, Spacek J.

Gynecol Oncol. 2005 Nov;99(2):334-8. Epub 2005 Jul 14.

PMID:
16023181
7.

Phase I trial of taxol as a radiation sensitizer with cisplatin in advanced cervical cancer.

Chen MD, Paley PJ, Potish RA, Twiggs LB.

Gynecol Oncol. 1997 Nov;67(2):131-6.

PMID:
9367695
9.

Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: a phase I/II study of the Gynecologic Oncology Group.

DiSilvestro PA, Walker JL, Morrison A, Rose PG, Homesley H, Warshal D; Gynecologic Oncology Group.

Gynecol Oncol. 2006 Dec;103(3):1038-42. Epub 2006 Aug 4.

PMID:
16889823
10.

Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.

Chung YL, Jian JJ, Cheng SH, Hsieh CI, Tan TD, Chang HJ, Hung CF, Horng CF, Soong T, Tsou MH.

Gynecol Oncol. 2005 Apr;97(1):126-35.

PMID:
15790448
11.

[Adjuvant simultaneous radiochemotherapy after operated uterine cervix carcinoma in high risk situation. Results of a pilot study].

Hänsgen G, Kuhnt T, Pigorsch S, Strauss H, Dunst J.

Strahlenther Onkol. 2002 Feb;178(2):71-7. German.

PMID:
11942040
12.

Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.

Kim JS, Kim JS, Kim SY, Kim Ki, Cho MJ.

Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1247-53. Review.

PMID:
12654434
13.

A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.

Gatcliffe TA, Tewari KS, Shah A, Brewster WR, Burger RA, Kuo JV, Monk BJ.

Gynecol Oncol. 2009 Jan;112(1):85-9. doi: 10.1016/j.ygyno.2008.09.029. Epub 2008 Nov 1.

14.

Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.

Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T; Radiation Therapy Oncology Group.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):168-73.

PMID:
15093913
15.

A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer.

Duska LR, Berkowitz R, Matulonis U, Muto M, Goodman A, McIntyre JF, Klein A, Atkinson T, Seiden MV, Campos S.

Gynecol Oncol. 2005 Jan;96(1):198-203.

PMID:
15589601
16.

Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer.

Park DC, Kim JH, Lew YO, Kim DH, Namkoong SE.

Gynecol Oncol. 2004 Jan;92(1):59-63.

PMID:
14751139
17.

Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix.

Fields AL, Anderson PS, Goldberg GL, Wadler S, Beitler J, Sood B, Runowicz CD.

Gynecol Oncol. 1996 Jun;61(3):416-22.

PMID:
8641625
18.

[Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].

Lerouge D, Touboul E, Lefranc JP, Uzan S, Jannet D, Moureau-Zabotto L, Genestie C, Antoine M, Jamali M.

Cancer Radiother. 2004 Jun;8(3):168-77. French.

PMID:
15217584
19.
20.

Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer.

Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T.

Gynecol Oncol. 2006 Oct;103(1):155-9. Epub 2006 Mar 20.

PMID:
16545437

Supplemental Content

Support Center